Adverse events · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: ECM changes change in weight (kg) compared with ECT (very low certainty).
1 finding from 1 review
Change in height · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
FEV1 change from start of treatment (L) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
FEV1 change from start of treatment (% predicted) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Time to next exacerbation · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Adverse events: number of moderate adverse events · adults and children with cystic fibrosis and P aeruginosa
The intervention showed no clear difference in adverse events: number of moderate adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Sputum density: change in P aeruginosa sputum density (log1₀ CFU/g) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Quality of life: change in CFQ‐R score from start of treatment · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Final height and change in height · people with thalassaemia (any age)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects Oral glucose tolerance test (mg/dL) (at one year) · people with thalassaemia (any age)
1 finding from 1 review
Intervention not reported
Height SDS(at one year) · people with thalassaemia (any age)
1 finding from 1 review
Intervention not reported
Change in height SDS (difference between baseline and final visit at one year) · people with thalassaemia (any age)
1 finding from 1 review
Intervention not reported
Height velocity (cm/year) · people with thalassaemia (any age)
1 finding from 1 review
Intervention not reported
Height velocity SDS · people with thalassaemia (any age)
1 finding from 1 review
Intervention not reported
Change in height velocity SDS (difference between baseline and final visit at one year) · people with thalassaemia (any age)
1 finding from 1 review
Annual rate of change in % predicted FEV1 All participants · adults and children with cystic fibrosis
1 finding from 1 review
Annual rate of change in % predicted FEV1 Subgroup: under 13 years of age · adults and children with cystic fibrosis
1 finding from 1 review
Annual rate of change in % predicted FEV1 Subgroup: over 13 years of age · adults and children with cystic fibrosis
1 finding from 1 review